Metabolism of ticagrelor in patients with acute coronary syndromes - Wikidata - awgldk - TriplyDB

Metabolism of ticagrelor in patients with acute coronary syndromes

Metabolism of ticagrelor in patients with acute coronary syndromes

http://www.wikidata.org/entity/Q58799733

about

Metabolism of ticagrelor in patients with acute coronary syndromes

http://www.wikidata.org/entity/Q58799733

description

article publié dans la revue scientifique Scientific Reports

@fr

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Scientific Reports

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Metabolism of ticagrelor in patients with acute coronary syndromes

@en

Metabolism of ticagrelor in patients with acute coronary syndromes

@nl

type

label

Metabolism of ticagrelor in patients with acute coronary syndromes

@en

Metabolism of ticagrelor in patients with acute coronary syndromes

@nl

prefLabel

Metabolism of ticagrelor in patients with acute coronary syndromes

@en

Metabolism of ticagrelor in patients with acute coronary syndromes

@nl

P1433

Q58799733-15AD326A-76D2-4D36-B16C-CA7E736A10D3

P1476

Q58799733-ACBEBC59-9824-4758-A8F6-1026CDFEA435

P2093

Q58799733-164EE434-8D03-415C-88DE-3A678A4A37F1

Q58799733-200904FC-7422-4A48-8834-72121712E652

Q58799733-5422B48A-CA9B-43E1-AD0B-6D8878632C84

Q58799733-97F7E0D8-0A4B-4077-BBAE-02802BF62138

Q58799733-99E1D0AB-96C2-416C-98B4-C714E574B35C

Q58799733-C22D6B30-1359-4B73-BC93-8B7034DC22F6

Q58799733-C59C3C6D-28A6-466D-99C4-40A8C46AA1A0

P2860

Q58799733-0203F353-6F56-4601-8D7D-CEBE9DFDC1EB

Q58799733-1133C5FE-ECC4-48CC-8E92-A3FE90BFA98D

Q58799733-174B9806-C609-415B-8569-ECAFDB514D3B

Q58799733-1E2372E6-2DE9-4BA1-9366-808C6BB12F54

Q58799733-31D82917-8C37-44D0-8A43-BE205A063CF2

Q58799733-3275BBF8-AE49-4E64-BE26-13DBDA946FBD

Q58799733-33444655-9208-4FE8-AFC8-FD9CF9DD94E8

Q58799733-39B24098-8455-4A63-AAC5-4DEF4FAE0677

Q58799733-3B0D8A2D-636E-429D-BE45-E2FFE99CF866

Q58799733-401C4D57-D253-4364-8BBA-EEFBB37D4467

P304

Q58799733-3D01C011-6786-47EB-890E-7EA03E0CD4A7

P31

Q58799733-77FA2EFD-22A7-4C21-A838-98F43729E72C

P356

Q58799733-E10AADF3-A1C0-4537-8E0F-5EA1C1602F4C

P407

Q58799733-E9D92D19-0279-4226-A68E-D86E0224127C

P433

Q58799733-C433C6FC-1D65-4FAE-B542-12AFB1B915F0

P478

Q58799733-FF133E3C-C0C4-4040-B591-3CB89E113240

P50

Q58799733-6C9FA6D3-D8FF-4021-AFA8-DD7932607697

Q58799733-78F073C8-4F5D-49C0-AB1F-AB9D9DA7AEB9

Q58799733-F045CFB3-137D-4AEC-A965-3E4FADAC45FC

P577

Q58799733-3F17421B-A0E1-403C-94BB-B487D2847326

P698

Q58799733-9174CD19-323B-4527-8AB5-9794E9595074

P932

Q58799733-9C496887-0DDD-4015-A51A-203754684D91

P356

S41598-018-29619-9

P1433

Scientific Reports

P1476

Metabolism of ticagrelor in patients with acute coronary syndromes

@en

P2093

Diana A Gorog

http://www.w3.org/2001/XMLSchema#string

Eliano P Navarese

http://www.w3.org/2001/XMLSchema#string

Joanna Sikora

http://www.w3.org/2001/XMLSchema#string

Katarzyna Buszko

http://www.w3.org/2001/XMLSchema#string

Małgorzata Ostrowska

http://www.w3.org/2001/XMLSchema#string

Piotr Niezgoda

http://www.w3.org/2001/XMLSchema#string

Przemysław Paciorek

http://www.w3.org/2001/XMLSchema#string

P2860

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors

Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update

Antiplatelet therapy for ischemic heart disease

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Opioid metabolism

Determination of ticagrelor and two metabolites in plasma samples by liquid chromatography and mass spectrometry.

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial.

P304

11746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-29619-9

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Malwina Barańska

P577

2018-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30082687

http://www.w3.org/2001/XMLSchema#string

P932

6078957

http://www.w3.org/2001/XMLSchema#string